Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,160 | -86,908 | -59,273 | -39,321 | -18,789 |
| Depreciation Amortization | 198 | 797 | 607 | 414 | 208 |
| Accounts receivable | -202 | 139 | 26 | -14 | -10 |
| Accounts payable and accrued liabilities | -2,161 | 368 | -2,319 | -4,283 | -1,865 |
| Other Working Capital | -4,397 | -1,195 | 2,388 | -3,166 | -3,534 |
| Other Operating Activity | 8,369 | 19,232 | 10,119 | 5,735 | 3,021 |
| Operating Cash Flow | $-26,353 | $-67,567 | $-48,452 | $-40,635 | $-20,969 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -553 | -605 | -500 | -350 | -164 |
| Purchase Of Investment | -28,524 | -164,753 | -118,729 | -85,096 | -14,558 |
| Sale Of Investment | 54,875 | 177,986 | 129,155 | 94,155 | 44,654 |
| Investing Cash Flow | $25,798 | $12,628 | $9,926 | $8,709 | $29,932 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 72,901 | 72,864 | 72,864 | 37 |
| Other Financing Activity | 0 | -34 | -34 | -23 | -7 |
| Financing Cash Flow | $N/A | $72,867 | $72,830 | $72,841 | $30 |
| Beginning Cash Position | 45,277 | 27,349 | 27,349 | 27,349 | 27,349 |
| End Cash Position | 44,722 | 45,277 | 61,653 | 68,264 | 36,342 |
| Net Cash Flow | $-555 | $17,928 | $34,304 | $40,915 | $8,993 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,353 | -67,567 | -48,452 | -40,635 | -20,969 |
| Capital Expenditure | -553 | -605 | -500 | -350 | -164 |
| Free Cash Flow | -26,906 | -68,172 | -48,952 | -40,985 | -21,133 |